Further:Studies have shown that somewhere between 80-95% of children with gender dysphoria are no longer dysphoric after puberty.
The drugs being used to transition children and teens are being used off-label and are not FDA approved for the purpose.
Patients of all ages who suffer from gender dysphoria should receive compassion and be protected from harm.
However, medical science does not support the invasive medical treatment of children and teens.
There is no other disorder for which we would accept this type of uncertainty in the treatment of children.